Back to Treatments

Treatment

Oxybutynin (low-dose extended release)

1
Conditions
8
Trials
1,500
Participants
55%
Average Safety

Condition Evidence

Menopause

8 trials · 1,500 participants

60% effectiveness · 55% safety
Oxybutynin (low-dose extended release) | DFDA